People used O-Mira.
Early users reported a different relationship with the phone they keep close every day.
M.I.D.™ Technology
Why we believe in M.I.D.™
O-Mira did not start from fear of technology. It started from a simple question: if the phone is now one of the objects we keep closest to the body every day, can that relationship be designed more responsibly?
Early users shared their experiences. We decided the responsible next step was not to exaggerate, but to measure.
Experience to measurement
Independent lab analysis
Passive material platform
Non-blocking by design
The starting point
First, people felt a difference.
O-Mira was built for real daily phone life: the hand, the pocket, the desk, the car, the bedroom, and the moments when the phone stays close for hours.
As early users began describing a lighter, calmer relationship with their phone, we wanted to understand what could be happening at a deeper level.
That changed the question from “Do people feel something?” to “Can we observe a measurable biological signal when the M.I.D.™ material is introduced under laboratory conditions?”
Confidence should not come from a promise. It should come from a process: listen, question, measure, verify, and keep improving.
The pathway
How we moved from experience to evidence.
The story is simple. We listened to users, then looked for measurable signals that could help explain why O-Mira exists.
O-Mira asked a better question.
Instead of turning experience into exaggerated claims, we looked for signals that could be measured.
ENERLAB analyzed it.
Independent laboratory work observed measurable changes in human blood and plasma samples exposed to the M.I.D.™ material.
CEA Nice confirmed a change.
Blood-sample tests performed at CEA Nice showed measurable changes consistent with ENERLAB’s observations.
Independent analysis
Measured by ENERLAB. Confirmed through CEA Nice testing.
For O-Mira, the role of laboratory work is not to create medical promises. It is to understand whether the M.I.D.™ material is associated with measurable biological signal changes under controlled conditions, and whether those changes can be observed again through a separate confirmation pathway.
Initial independent analysis.
Initial analyses were conducted by ENERLAB, an independent laboratory in France, using human blood and plasma samples.
The observations focused on ultra-weak biological light emission, also known as ultra-weak photon emission, a faint signal studied in biological systems.
O-Mira presents this as a measurement and confirmation pathway, not as a medical claim or institutional endorsement.
Step 1
Customer experience raised the question.
People described a more balanced relationship with their phone, so O-Mira looked for a measurable way to investigate.
Step 2
ENERLAB performed the initial analysis.
Human blood and plasma samples were studied before and after exposure to O-Mira’s M.I.D.™ material.
Step 3
CEA Nice testing confirmed a measurable change in blood samples.
Tests performed at CEA Nice showed changes consistent with ENERLAB’s observations. This confirms the presence of a biological signal change, without presenting CEA as endorsing the product or making a medical claim.
What was observed
When M.I.D.™ was introduced, measurable signals changed.
In the initial ex vivo analysis, the M.I.D.™ material used in O-Mira was associated with measurable changes in human blood and plasma samples. These are laboratory observations, not clinical outcomes.
+129%
Blood light signal
Observed ultra-weak biological light emission shift in whole blood samples after exposure to O-Mira’s M.I.D.™ material.
+145%
Plasma light signal
Observed ultra-weak biological light emission shift in plasma samples within the same research direction.
300–400 → 400–500
Spectral profile
The observed wavelength distribution shifted. In plain language: not only more signal, a different signal profile.
These observations help explain why O-Mira speaks about modulation. They do not diagnose, treat, cure, prevent disease, or guarantee an individual outcome.
Simple definition
What M.I.D.™ means.
M.I.D.™ stands for Mode d’Information Dynamisant.
In O-Mira One, it refers to a passive material platform designed to sit between the smartphone and the body, without battery, app, Bluetooth, charging, or signal-blocking mechanism.
O-Mira does not ask you to disconnect. It is designed to change the relationship.
✓
Material, not electronics.
No battery, software, firmware, pairing, or charging cycle.
✓
Interface, not interruption.
The product adds a passive material layer to the phone you already use.
✓
Modulation, not blocking.
Calls, Wi‑Fi, Bluetooth, 5G, and mobile data are intended to continue normally.
✓
Measured, not mystical.
The O-Mira story is built around laboratory observation and ongoing validation.
Responsible language
Careful science makes the story stronger.
What we can say
- O-Mira One uses a passive M.I.D.™ material platform.
- ENERLAB performed independent laboratory analysis on human blood and plasma samples.
- Blood-sample tests performed at CEA Nice showed measurable changes consistent with ENERLAB’s observations.
- Initial observations showed measurable changes in biological light signal behavior.
What we do not claim
- Not a medical device, diagnosis, treatment, cure, or prevention product.
- Not clinical proof or a guaranteed personal outcome.
- Not a Faraday shield, EMF blocker, or phone-signal reducer.
- Not a product endorsement, medical endorsement, or certification by ENERLAB, CEA, or any third party unless separately stated in authorized documentation.
Keep the connection. Change the relationship.
O-Mira One brings M.I.D.™ technology into a discreet, French-made smartphone format: passive, non-blocking, and developed from experience toward measurable biological observation.
